Alkacel (Melphalan) — Patient Information (UK)

Alkacel is a medicine containing melphalan, an anti-cancer (cytotoxic) drug used to treat certain types of blood cancers and, in some situations, specific solid tumours. This guide explains how it works, how it is used, key safety points, and practical guidance to help you understand your treatment.

Medicines like Alkacel can be complex and affect blood counts, immunity, and the digestive system. Your healthcare team will tailor the plan to your situation. Always follow the instructions given to you by your clinician.

1. Basic product information

Note: Alkacel may be supplied in forms and strengths determined by your treatment protocol. Ask your healthcare team to confirm the exact product and schedule you have been given.

2. How Alkacel works (mechanism of action)

Melphalan is an alkylating agent. It damages the genetic material inside rapidly dividing cells (including cancer cells), making it harder for those cells to grow and divide.

In simple terms, melphalan attaches to DNA and prevents normal cell replication. This effect can also occur in healthy fast-growing tissues such as bone marrow and the lining of the gut, which is why side effects like low blood counts and nausea may occur.

3. Pharmacokinetics (what the body does with the drug)

Pharmacokinetics describes how a medicine moves through the body: absorption (if applicable), distribution, metabolism, and excretion.

• Distribution: After administration, melphalan can distribute into tissues. The extent of distribution and tissue penetration may vary with dosing and treatment context.
• Metabolism: Melphalan is metabolised in the body, with breakdown products that may be inactive.
• Elimination: The drug and its metabolites are mainly cleared from the body through excretion pathways, with the kidneys and other mechanisms contributing depending on the formulation and patient factors.
• Clinical implication: Because melphalan can affect bone marrow, careful monitoring of blood counts is important. Kidney function and overall health may influence dosing decisions.

Your clinician will consider factors such as age, kidney function, prior treatments, and blood results when planning your regimen.

4. Typical use in the UK

Alkacel (melphalan) is used in specialist oncology settings for conditions where an alkylating agent is appropriate. Common uses include:

• Multiple myeloma (a cancer of plasma cells). Melphalan is often used as part of chemotherapy regimens, and may be combined with other medicines.
• Other plasma cell disorders depending on local protocols and clinical judgement.
• Selected solid tumours in particular circumstances, depending on availability of evidence and specialist assessment.

Your treatment plan may include single-agent melphalan or combination therapy. The exact regimen, cycle length, and supportive medicines (such as anti-sickness medication) are chosen to balance benefit and tolerability.

5. Timing: when doses are given and what to expect

Alkacel is typically administered in cycles, allowing time for your body (especially bone marrow) to recover between doses. The specific schedule depends on the regimen.

What you might notice around treatment days

• First 24–72 hours: Some people experience nausea, vomiting, tiredness, or reduced appetite.
• Days 4–14: This period may be when blood counts drop (neutropenia risk). Your clinic will monitor full blood counts frequently.
• After recovery: Energy may improve before the next cycle begins.

Always keep to your appointments for blood tests and symptom checks. If your clinic has given you “red flag” instructions for fever or infection symptoms, follow them promptly.

6. Food interactions and dietary considerations

Food interactions depend on the formulation and how the medicine is administered in your regimen. For some chemotherapy medicines, certain foods may influence absorption or nausea.

Practical guidance

• Follow clinic instructions: If your regimen includes guidance on fasting or taking with/without food, follow that precisely.
• For nausea: Small, frequent meals can help. Choose bland, low-odour foods if you feel sick.
• Hydration: Aim for adequate fluids unless you’ve been told to restrict fluids. Dehydration can worsen side effects.
• Diarrhoea management: If diarrhoea occurs, maintain hydration and speak to your team for advice.

If you are unsure whether you need to take anything on an empty stomach or with food, ask your pharmacy team or clinic.

7. Alcohol and medicine interactions

Because Alkacel is a cytotoxic chemotherapy, it may be used alongside other medicines that have their own interaction profiles. Alcohol can worsen dehydration, increase nausea, and affect your ability to tolerate treatment.

Alcohol: general advice

• Avoid or limit alcohol: Many oncology teams advise minimising alcohol during chemotherapy.
• Be cautious with fatigue: Alcohol can increase tiredness and reduce safety when taking medicines that cause drowsiness.
• Risk of interactions: If you take anti-sickness medicines, opioids, or sedating antihistamines, alcohol may increase side effects.

Medication interactions to discuss with your team

Tell your clinician/pharmacist about:

• Other chemotherapy or targeted therapies
• Immunosuppressants
• Antibiotics and antifungals (especially if infection occurs)
• Antiemetics (anti-sickness medicines)
• Blood thinners (anticoagulants) or medicines that affect bleeding risk
• Herbal products and supplements (some may interact or affect your liver/kidneys)

Your oncology pharmacy team will check compatibility with your full medication list.

8. Indications (what conditions it is used for)

Alkacel (melphalan) is indicated in specialist practice for certain cancers, particularly:

• Multiple myeloma and related plasma cell disorders, typically as part of combination chemotherapy protocols.
• Other malignancies in carefully selected cases, depending on evidence, availability, and specialist guidance.

Exact eligibility depends on diagnosis, stage, prior treatments, and your individual risk factors. If you’d like, ask your clinic what the goal is for your specific regimen (for example, disease control, response before transplant, or symptom management).

9. Dosing and administration (general information)

Dosing with chemotherapy is calculated carefully, often based on:

• Body surface area (BSA) and/or other clinical measures
• Kidney function
• Blood counts and prior treatment tolerance
• Regimen type (single agent vs combination; cycle timing)

Because chemotherapy dosing is highly individualised, this website cannot provide a personalised dose. Your clinician will confirm the exact dose, schedule, and how it is given for your condition.

Monitoring around dosing

• Full blood count (FBC): to detect neutropenia, anaemia, and platelet changes.
• Renal (kidney) and liver function tests: to assess fitness for treatment.
• Symptom review: nausea, vomiting, mouth sores, diarrhoea, and signs of infection.

Your clinic may delay a cycle or adjust doses if blood counts are low or if side effects are significant.

10. Safety profile: side effects and when to seek help

Like all chemotherapy medicines, Alkacel can cause side effects. Not everyone will experience them, and many can be managed with supportive treatment.

Common side effects

• Nausea and vomiting
• Diarrhoea or digestive upset
• Reduced appetite
• Fatigue and weakness
• Low blood counts (including neutropenia, anaemia, and low platelets)
• Mouth ulcers / mouth inflammation
• Hair thinning (varies by regimen)

Serious risks (seek urgent medical advice)

Contact your treatment team urgently or seek emergency care if you experience:

• Fever or chills, especially if you feel unwell (a possible serious infection when neutrophils are low)
• Signs of infection such as sore throat, cough with breathlessness, burning when urinating, or persistent diarrhoea
• Severe bleeding or unusual bruising (possible low platelets)
• Severe mouth pain, difficulty swallowing, or dehydration
• Allergic reactions such as swelling of the face/lips, rash, or breathing difficulty
• Severe allergic/infusion reactions if given intravenously (reported symptoms should be acted on immediately by staff)

Fertility and pregnancy/breastfeeding

Alkylating agents can affect fertility and may harm an unborn baby. It is important to discuss:

• Contraception during and after treatment (your oncology team will advise exact timing)
• Fertility preservation options if relevant before starting treatment
• Breastfeeding guidance, which is typically not recommended during chemotherapy

Long-term safety considerations

• Secondary malignancies: chemotherapy can slightly increase the risk of developing another cancer later in life (your clinician can discuss absolute risks).
• Organ effects: kidney and other organ function should be monitored, particularly in those with pre-existing disease.

11. Practical use tips (day-to-day guidance)

These tips can make treatment days more manageable. Your clinic’s advice always takes priority.

Before each cycle

• Plan support: Arrange transport for appointments if you may feel unwell afterwards.
• Prepare anti-sickness medicines: Many patients receive prescriptions for nausea prevention. Ensure you understand how and when to take them.
• Stock up on essentials: Oral care items, hydration supplies, thermometers, and any recommended treatments for mouth sores.
• Know your “when to call” signs: Ask your team what temperature or symptoms require immediate contact.

During treatment

• Hydrate: Sip fluids regularly. If your clinic has given fluid targets, follow them.
• Manage constipation/diarrhoea early: Don’t wait until symptoms worsen. Contact your team for guidance.
• Protect your mouth: Gentle brushing with a soft brush, regular mouth rinses (as advised), and reporting mouth pain early.
• Reduce infection risk: Practice good hand hygiene; avoid close contact with people who have contagious infections.
• Rest and pacing: Fatigue is common—short periods of activity with rest often help.

After a cycle

• Attend blood tests: They guide whether doses proceed as planned.
• Track symptoms: Keeping a simple diary (nausea, bowel habits, temperature, infections) can help your clinician.
• Ask about recovery time: You may be more vulnerable to infection after counts drop; your team may give tailored advice.

12. Alternative options

Treatment for multiple myeloma and other cancers is individualised. Alternatives may include:

• Other chemotherapy agents used alone or in combination regimens
• Targeted therapies (for example, certain immunomodulatory drugs or proteasome inhibitors, depending on diagnosis and line of treatment)
• Immunotherapies and newer agents where appropriate
• Stem cell transplant (in some myeloma pathways) where melphalan may be part of conditioning regimens
• Supportive care (e.g., anti-sickness medicines, infection prevention/monitoring, growth factors if prescribed)

Ask your specialist team what the rationale is for choosing melphalan in your particular case and what alternatives are available if side effects become difficult to manage.

13. UK market and legal context

In the United Kingdom, cancer chemotherapy is provided through specialist services and is regulated under medicines and healthcare quality frameworks. Medicines must meet UK regulatory standards for quality, safety, and effectiveness, and are supplied in accordance with the prescribing and dispensing arrangements used by the NHS and private providers.

Alkacel (melphalan) is part of the UK oncology medicine landscape, and availability can depend on manufacturer supply, local hospital formularies, and the specific formulation required for your regimen.

Recent guidance (UK-focused)

Guidance in the UK continues to emphasise:

• Risk-based monitoring for infection, blood count changes, and supportive care.
• Standardised anti-sickness prophylaxis for chemotherapy-related nausea and vomiting, with escalation if needed.
• Clear “patient safety” pathways for fever and neutropenia symptoms, including fast access to urgent assessment.
• Medication reconciliation to reduce interaction risk and improve adherence to complex regimens.

Your clinic may also follow national or service-specific protocols from NHS trusts, professional bodies, and local cancer networks.

14. Delivery and availability (UK)

Availability and delivery of chemotherapy-related medicines are typically managed through specialist supply chains. Where home delivery is relevant, it must follow strict handling and storage requirements and the dispensing process used in the UK.

• Stock levels: Delivery times may vary due to supply fluctuations.
• Storage requirements: Follow any storage instructions on the packaging. If you are unsure, ask before storing at home.
• Collection/delivery arrangements: Some regimens involve collection or delivery directly to the treatment site.

To confirm what is possible in your specific area, check the product listing on the pharmacy website or speak to a member of the pharmacy team before placing an order.

15. FAQ

What is Alkacel used for?

Alkacel contains melphalan and is used in specialist chemotherapy regimens, most commonly in conditions such as multiple myeloma and sometimes other selected cancers. Your clinic will explain the goal of your specific regimen.

How does melphalan cause side effects like low blood counts?

Melphalan affects rapidly dividing cells. Bone marrow is one of the most actively dividing tissues in the body, so chemotherapy can temporarily reduce white blood cells, red blood cells, and platelets.

When should I contact my healthcare team urgently?

Contact your team urgently if you develop fever, feel severely unwell, notice signs of infection (such as shortness of breath, persistent diarrhoea, or burning on urination), or experience unusual bleeding/bruising.

Can I eat normally while taking Alkacel?

Many people can eat, but nausea and appetite changes are common. Small, frequent meals and hydration often help. If you have persistent vomiting, diarrhoea, or are unable to drink, contact your team.

Are there any food restrictions?

Food advice depends on your exact regimen and the formulation. Follow your clinic’s instructions. If you are taking any supportive medicines for side effects, ask your pharmacy if there are food considerations for those medicines.

Can I drink alcohol during treatment?

Alcohol can worsen dehydration and nausea and may increase sedation when combined with certain medicines. Many oncology teams advise avoiding or limiting alcohol during chemotherapy. Discuss what is safest for you.

What medicines should I avoid?

Do not start, stop, or change medicines without checking first. Include in your discussion: antibiotics, antifungals, pain medicines, blood thinners, anti-sickness medicines, herbal products, and supplements. Your clinic can advise based on your full medication list.

How long does treatment last?

Treatment is given in cycles and the total duration depends on response and tolerability. Your team will set out the plan and review it over time using symptoms and test results.

Will Alkacel affect fertility?

It may. Discuss fertility preservation and contraception early with your clinician, so you can make informed decisions before or during treatment.

Where can I get help if I feel unwell between appointments?

Your clinic should provide contact numbers and advice. Keep those details to hand. If you cannot reach your team and you have serious symptoms (such as fever or breathing difficulties), seek urgent medical help.

Important safety note

This information is intended to help you understand Alkacel (melphalan) and is not a substitute for personalised medical advice. Chemotherapy can be dangerous if misused or handled incorrectly. If you have questions about side effects, interactions, or your schedule, contact your oncology team or pharmacist.